Dr. Vogel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 N Academy Ave
Danville, PA 17822Phone+1 570-271-6045Fax+1 570-271-6542
Summary
- Victor G. Vogel, MD, MHS, FACP is the Director of the Cancer Service Line of the Geisinger Health System. Prior to his current appointment, Dr. Vogel served as the National Vice President for Research at the American Cancer Society.
Dr. Vogel was previously Professor of Medicine and Epidemiology at the University of Pittsburgh School of Medicine from, and Co-Director of the Magee-Womens Hospital/University of Pittsburgh Cancer Institute Biochemoprevention Program. He served as the National Protocol Chairman of the National Cancer Institutes STAR Trial (Study of Tamoxifen and Raloxifene), and serves on the Board of Directors of the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical cooperative group.
Dr. Vogel is the author of more than 250 articles, book chapters, and abstracts. He edited the books Management of Patients at High Risk for Breast Cancer and Handbook of Breast Cancer Risk Assessment: Evidence-Based Guidelines for Evaluation, Prevention, Counseling, and Treatment.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1983 - 1986
- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1978 - 1981
- Lewis Katz School of Medicine at Temple UniversityClass of 1978
Certifications & Licensure
- PA State Medical License 1995 - 2024
- TX State Medical License 1987 - 1996
- MD State Medical License 1979 - 1987
- WV State Medical License 1981 - 1985
- American Board of Internal Medicine Internal Medicine
- American Board of Preventive Medicine Public Health & General Preventive Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1081 citationsEffects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 ...Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin, Reena S. Cecchini
JAMA. 2006-06-21 - 3930 citationsTrastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer
The New England Journal of Medicine. 2005-10-20 - 683 citationsVenoocclusive disease of the liver following bone marrow transplantationRichard J. Jones, Kamthorn S. K. Lee, William E. Beschorner, Victor G. Vogel, Louise B. Grochow
Transplantation. 1987-12-01
Press Mentions
- ‘How Am I Doing, Doc?’April 15th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: